SMTL ID : 5tq7.1 (1 other biounit)

Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x 7GT: {(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}[(3R)-3-(phenylsulfonyl)pyrrolidin-1-yl]methanone(Non-covalent)

7GT.1: 19 residues within 4Å: Chain A: L.27, G.28, K.29, G.30, F.32, G.33, S.34, V.35, A.52, K.54, E.102, Y.103, L.104, S.108, R.152, N.153, L.155, G.165, D.166 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.35, A:L.155, A:L.155 Hydrogen bonds: A:E.102, A:L.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jones, P. et al., Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. J. Med. Chem. (2017)

Release Date

2017-01-11

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence